X

WeightWatchers Enters the Obesity Drug Market Upon Acquisition of a Digital Health Platform

By: Geraldine Ciaccio, PharmD Candidate c/o 2025 The personalized weight-loss program WeightWatchers took a significant step into the newly popularized…

eMAR

Evaluation of Haloperidol for Treatment of ICU Delirium

By: Nancy Yousry, PharmD Candidate c/o 2024 Delirium is characterized as impaired cognition with a wide range of manifestations that…

eMAR

6th Year Perspective: Industry Elective APPE with Pfizer

Featuring: Isabella Chow, PharmD Candidate c/o 2024By: Isabelle Lim, PharmD Candidate c/o 2024 Isabella Chow is a sixth-year pharmacy student…

eMAR

New Study Expands Pharmacists’ Role in Treating Opioid Use Disorder

By: Geraldine Ciaccio, PharmD Candidate c/o 2025 ​The role of pharmacists in public health has been expanding in recent years.…

eMAR

Zavegepant: An Intranasal Breakthrough in Treating Acute Migraine Attacks

By: Samia Rahman Adity, PharmD Candidate c/o 2025               Migraine has been a throbbing topic of discussion and a serious…

eMAR

FDA Regulatory Change Expands Access to Mifepristone

By: Ashley Dao, PharmD Candidate c/o 2024 Medical abortion is approved by the Food and Drug Administration (FDA) to end…

eMAR

Rho Chi Talks: Tips to Acquirea Residency

Featuring: Krishna Tamakuwala, PharmDBy: Justin Budz, PharmD Krishna Tamakuwala is a recent graduate from the St. John’s University Doctor of…

eMAR

U.S. Based Pharmaceutical Manufacturer, Eli Lilly & Co., Caps Off Insulin Prices as the Country Pushes to Make the Medication Affordable for Patients

By: Urooj K. Malik, PharmD Candidate c/o 2024 March 1, 2023 marked a substantial milestone in the United States’ (U.S.’)…

eMAR

A Message from the Editor-in-Chief – Isabelle Lim

Congratulations to the sixth-year pharmacy students for graduating and to the rest of the student body for completing another year…

eMAR

Evaluation of Ivermectin for Treatment of COVID-19

By: Isabelle Lim, PharmD Candidate c/o 2024 and Justin Budz, PharmD Candidate c/o 2023 Coronavirus disease 2019 (COVID-19) is an…

eMAR